Overview

A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Purpose of Study • The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
TriHealth Inc.